Endothelin antagonism and its role in the treatment of hypertension.

Abstract:

:Hypertension contributes greatly to global disease burden and in many patients current treatments do not adequately control blood pressure (BP). Endothelin-1 (ET-1) is a potent vasoconstrictor that is implicated in the pathogenesis of hypertension, including the hypertension that is often associated with chronic kidney disease (CKD) and the metabolic syndrome. ET receptor antagonists, currently licensed for the treatment of pulmonary arterial hypertension and scleroderma-related digital ulcers, are being investigated for the treatment of hypertension. Clinical trials have addressed the use of ET receptor antagonists as monotherapy in primary hypertension, as an add-on therapy in resistant hypertension and in CKD. This review will evaluate the current evidence regarding the therapeutic potential of ET receptor antagonists in hypertension, as well as highlighting important issues that still need to be addressed.

journal_name

Curr Hypertens Rep

authors

Moorhouse RC,Webb DJ,Kluth DC,Dhaun N

doi

10.1007/s11906-013-0380-1

subject

Has Abstract

pub_date

2013-10-01 00:00:00

pages

489-96

issue

5

eissn

1522-6417

issn

1534-3111

journal_volume

15

pub_type

杂志文章,评审
  • Sodium intake and blood pressure in children.

    abstract::Elevation of blood pressure (BP) and the risk for progression to hypertension (HTN) is of increasing concern in children and adolescents. Indeed, it is increasingly recognized that target organ injury may begin with even low levels of BP elevation. Sodium intake has long been recognized as a modifiable risk factor for...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-013-0382-z

    authors: Hanevold CD

    更新日期:2013-10-01 00:00:00

  • Effects of relaxin on arterial dilation, remodeling, and mechanical properties.

    abstract::Administering relaxin to conscious rats and humans elicits systemic and renal vasodilation. The molecular mechanisms vary according to the duration of relaxin exposure-so-called "rapid" (within minutes) or "sustained" (hours to days) vasodilatory responses-both being endothelium-dependent. Rapid responses are mediated...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-011-0231-x

    authors: Conrad KP,Shroff SG

    更新日期:2011-12-01 00:00:00

  • Spironolactone in congestive heart failure.

    abstract::When a large multicenter research trial is abruptly terminated, it is usually a consequence of significant adverse events. In contrast, when the Randomized Aldactone Evaluation Study (RALES) mortality trial was discontinued 18 months early, it was because of the prominent salutary effect of spironolactone, added to st...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-000-0027-x

    authors: Soberman JE,Weber KT

    更新日期:2000-10-01 00:00:00

  • Low Birth Weight, Blood Pressure and Renal Susceptibility.

    abstract:PURPOSE OF THE REVIEW:The purpose of this review is to highlight the clinical significance of increased renal risk that has its origins in fetal life. This review will also discuss the critical need to identify therapeutic interventions for use in a pregnancy complicated by placental dysfunction and intrauterine growth...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-019-0969-0

    authors: Coats LE,Davis GK,Newsome AD,Ojeda NB,Alexander BT

    更新日期:2019-06-21 00:00:00

  • Resistant hypertension and aldosteronism.

    abstract::Resistant hypertension is defined as blood pressure that remains uncontrolled despite using at least three antihypertensive medications in effective doses, ideally including a diuretic. Stricter blood pressure goals, higher obesity rates, older age, and increased use of certain exogenous substances are related to an i...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-007-0066-7

    authors: Pimenta E,Calhoun DA

    更新日期:2007-11-01 00:00:00

  • Hypertension in the Emergency Department.

    abstract::Hypertension is the leading risk factor for the global burden of disease, yet more than 20% of adults with hypertension are unaware of their condition. Underlying hypertension affects over 25% emergency department attendees, and the condition is more commonly encountered in emergency departments than in primary care s...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-016-0647-4

    authors: Chan SS,Graham CA,Rainer TH

    更新日期:2016-04-01 00:00:00

  • Angiotensinogen variants and human hypertension.

    abstract::The research on molecular genetics of human hypertension aims to identify the loci involved in the regulation of blood pressure, detect gene variants within the identified loci, associate them with intermediate phenotypes, and ultimately estimate their quantitative effects on blood pressure level and their interaction...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-999-0071-0

    authors: Jeunemaitre X,Gimenez-Roqueplo AP,Célérier J,Corvol P

    更新日期:1999-02-01 00:00:00

  • Epinephrine and the metabolic syndrome.

    abstract::Epinephrine is the prototypical stress hormone. Its stimulation of all α and β adrenergic receptors elicits short-term systolic hypertension, hyperglycemia, and other aspects of the metabolic syndrome. Acute epinephrine infusion increases cardiac output and induces insulin resistance, but removal of the adrenal medull...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-011-0243-6

    authors: Ziegler MG,Elayan H,Milic M,Sun P,Gharaibeh M

    更新日期:2012-02-01 00:00:00

  • Immune mechanisms in hypertension.

    abstract::Inflammation plays an important role in the pathogenesis of hypertension. Innate and adaptive immune response may contribute to this process. The mechanisms implicating immune response in hypertension are still elusive. To date, the evidence originates in three major areas of data: cytokine production, central nervous...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-011-0224-9

    authors: Leibowitz A,Schiffrin EL

    更新日期:2011-12-01 00:00:00

  • The epithelial sodium channel in hypertension.

    abstract::Our understanding of Na(+) transport defects has exploded in the past several years, and has provided unique insights into epithelial transport processes, and unusual clinical syndromes resulting from mutations of specific ion transporters. These genetic disorders affect Na(+) balance, with both Na(+) retaining and Na...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-999-0013-x

    authors: Warnock DG

    更新日期:1999-04-01 00:00:00

  • Integrative Physiological Aspects of Brain RAS in Hypertension.

    abstract:PURPOSE OF REVIEW:The renin-angiotensin system (RAS) plays an important role in modulating cardiovascular function and fluid homeostasis. While the systemic actions of the RAS are widely accepted, the role of the RAS in the brain, its regulation of cardiovascular function, and sympathetic outflow remain controversial. ...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-018-0810-1

    authors: de Morais SDB,Shanks J,Zucker IH

    更新日期:2018-02-26 00:00:00

  • Modulation of pressure-natriuresis by renal medullary reactive oxygen species and nitric oxide.

    abstract::The renal pressure-natriuresis mechanism is the dominant controller of body fluid balance and long-term arterial pressure. In recent years, it has become clear that the balance of reactive oxygen and nitrogen species within the renal medullary region is a key determinant of the set point of the renal pressure-natriure...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-010-0094-6

    authors: O'Connor PM,Cowley AW Jr

    更新日期:2010-04-01 00:00:00

  • LCZ696: the next step in improving RAS inhibition?

    abstract::LCZ696 is a single molecule which combines the angiotensin receptor blocker valsartan with the neprilysn inhibitor sacubitril (AHU377). In the recently published PARADIGM-HF trial, LCZ696 proved superior to enalapril in reducing overall mortality, heart failure hospitalizations, and other endpoints in patients with sy...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-015-0548-y

    authors: Gradman AH

    更新日期:2015-05-01 00:00:00

  • Selective vs. Global Renal Denervation: a Case for Less Is More.

    abstract:PURPOSE OF REVIEW:Review the renal nerve anatomy and physiology basics and explore the concept of global vs. selective renal denervation (RDN) to uncover some of the fundamental limitations of non-targeted renal nerve ablation and the potential superiority of selective RDN. RECENT FINDINGS:Recent trials testing the ef...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-018-0838-2

    authors: Fudim M,Sobotka AA,Yin YH,Wang JW,Levin H,Esler M,Wang J,Sobotka PA

    更新日期:2018-05-01 00:00:00

  • Innovative Implementation Strategies for Hypertension Control in Low- and Middle-Income Countries: a Narrative Review.

    abstract:PURPOSE OF REVIEW:This review summarizes the most recent and innovative implementation strategies for hypertension control in low- and middle-income countries (LMICs). RECENT FINDINGS:Implementation strategies from Latin America, Africa, and Asia were organized across three levels: community, health system, and policy...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-020-01045-1

    authors: Mercer T,Nulu S,Vedanthan R

    更新日期:2020-05-13 00:00:00

  • Neurogenic factors in renal hypertension.

    abstract::Hypertension is very common in patients with chronic renal failure and contributes to cardiovascular morbidity and mortality. Several mechanisms may contribute to hypertension in these patients, but recently a large body of evidence supports the notion that activation of the sympathetic nervous system (SNS) may play a...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-002-0016-3

    authors: Campese VM,Krol E

    更新日期:2002-06-01 00:00:00

  • The genetic basis of primary aldosteronism.

    abstract::Primary aldosteronism is commonly regarded as largely sporadic, but both germline and somatic mutations are increasingly recognized as underlying the condition. Three germline mutations causing familial hyperaldosteronism have been described, dubbed FH I (due to a CYP11B1/CYP11B2 chimera), FH II (localized to chromoso...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-012-0255-x

    authors: Funder JW

    更新日期:2012-04-01 00:00:00

  • Obstructive sleep apnea and hypertension: a critical review.

    abstract::Obstructive sleep apnea (OSA) is a prevalent sleep disorder which is characterized by recurrent upper closure with oxygen desaturation and sleep disruption. OSA increases the risk of vascular disorders in the form of stroke, myocardial infarction, congestive heart failure, and hypertension. The mechanisms underlying t...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-014-0482-4

    authors: Mohsenin V

    更新日期:2014-10-01 00:00:00

  • Prevalence and diagnosis of primary aldosteronism.

    abstract::Primary aldosteronism (PA) is a common cause of arterial hypertension: in the PA Prevalence in Hypertensives (PAPY) Study, the prevalence of PA was 11.2% in consecutive referred hypertensive patients. When adrenal vein sampling (AVS) is available, two thirds of the cases can be attributed to a tumor and one third of c...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-010-0134-2

    authors: Rossi GP

    更新日期:2010-10-01 00:00:00

  • Treatment of diabetic patients with hypertension.

    abstract::This review attempts to highlight the potential of calcium-channel blockers in the prevention of sequelae of diabetes mellitus and hypertension in patients who have both disorders. Evidence-based medicine is driven by the results of randomized, clinical trials. Major contributions were therefore derived from post hoc ...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-999-0025-6

    authors: Birkenhäger WH,Staessen JA

    更新日期:1999-06-01 00:00:00

  • Impaired cardiac function in leptin-deficient mice.

    abstract::The obesity gene product leptin plays an important role in the physiologic regulation of appetite and energy balance. Plasma leptin levels correlate closely with body fat storage and may respond to changes in energy expenditure. Recent evidence has implicated a direct cardiac regulatory action of leptin in addition to...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-008-0084-0

    authors: Ren J,Ma H

    更新日期:2008-12-01 00:00:00

  • Insulin resistance in HIV-related lipodystrophy.

    abstract::Lipodystrophy (LD) associated with HIV infection is a syndrome of abnormal fat distribution observed in HIV-infected patients treated with various antiretroviral agents. In addition, insulin resistance and dyslipidemia can occur in HIV-infected patients with or without LD. The demonstration of the latter metabolic dis...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-003-0067-0

    authors: Mikhail N

    更新日期:2003-04-01 00:00:00

  • Antiplatelet treatment in essential hypertension: where do we stand?

    abstract::Antiplatelet agents represent a cornerstone in the management of patients at increased cardiovascular risk. Essential hypertension is considered a major public health problem leading to increased cardiovascular morbidity and mortality. The majority of patients with essential hypertension exhibit also additional cardio...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-015-0536-2

    authors: Gkaliagkousi E,Gavriilaki E,Douma S

    更新日期:2015-04-01 00:00:00

  • Circulating angiotensin II and dietary salt: converging signals for neurogenic hypertension.

    abstract::Circulating angiotensin II (Ang II) combined with high salt intake increases sympathetic nerve activity (SNA) in some forms of hypertension. Ang II-induced increases in SNA are modest, delayed, and specific to certain vascular beds. The brain targets for circulating Ang II are neurons in the area postrema (AP), subfor...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-007-0041-3

    authors: Osborn JW,Fink GD,Sved AF,Toney GM,Raizada MK

    更新日期:2007-06-01 00:00:00

  • The relationship between quality of life and adherence to treatment.

    abstract::Hypertension is a preventable condition, and the outcomes of clinical trials have established that its treatment reduces cardiovascular morbidity and mortality. Although awareness about the disease has improved in the past two decades, the reality is that many people remain untreated or not adequately controlled. The ...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-001-0007-9

    authors: Nunes MI

    更新日期:2001-12-01 00:00:00

  • Prehypertension: a possible target for antihypertensive medication.

    abstract::Vascular changes associated with elevated blood pressure may precede the clinical diagnosis of hypertension. Even after the diagnosis is made, associated coronary heart disease and renal disease continue to progress, despite adequate blood pressure control. Early treatment of blood pressure may reduce the incidence of...

    journal_title:Current hypertension reports

    pub_type: 临床试验,杂志文章,评审

    doi:10.1007/s11906-000-0038-7

    authors: Nesbitt SD,Julius S

    更新日期:2000-08-01 00:00:00

  • New Agents in Treatment of Hyperkalemia: an Opportunity to Optimize Use of RAAS Inhibitors for Blood Pressure Control and Organ Protection in Patients with Chronic Kidney Disease.

    abstract:PURPOSE OF REVIEW:The overactive renin-angiotensin-aldosterone system (RAAS) plays an important part in many pathologic conditions including hypertension, heart failure, and renal disease. Hyperkalemia, a potentially life-threatening side effect of RAAS inhibitors, limits their use. The recent introduction of new hyper...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-016-0663-4

    authors: Rastogi A,Arman F,Alipourfetrati S

    更新日期:2016-07-01 00:00:00

  • The Role of Arterial Hypertension in Mitral Valve Regurgitation.

    abstract:PURPOSE OF REVIEW:To review medical literature for evidence of association between hypertension and mitral regurgitation (MR) and summarize potential favorable effects of antihypertensive drugs on MR natural history and treatment. RECENT FINDINGS:Hypertension and MR are common diseases affecting a large proportion of ...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-019-0928-9

    authors: Katsi V,Georgiopoulos G,Magkas N,Oikonomou D,Virdis A,Nihoyannopoulos P,Toutouzas K,Tousoulis D

    更新日期:2019-02-28 00:00:00

  • Regulation of sodium/potassium ATPase activity: impact on salt balance and vascular contractility.

    abstract::Na+,K+-ATPase distributes ions between the intracellular and extracellular space and is responsible for total-body sodium homeostasis. The activity of this ion pump is regulated by catecholamines and peptide hormones; by the ligand of Na+,K+-ATPase, ouabain; and by direct interaction with cytoskeleton proteins. This r...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-001-0032-8

    authors: Aperia A

    更新日期:2001-04-01 00:00:00

  • Mineralocorticoid receptor blockade in chronic kidney disease.

    abstract::Aldosterone antagonists have been highly successful in treating congestive heart failure and resistant hypertension. Until recently, therapies targeting the mineralocorticoid receptor in chronic kidney disease (CKD) have received little attention, largely because of the risk of hyperkalemia and the incorrect assumptio...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-011-0202-2

    authors: Volk MJ,Bomback AS,Klemmer PJ

    更新日期:2011-08-01 00:00:00